These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 6108332

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease.
    Tamaki H, Amino N, Aozasa M, Mori M, Tanizawa O, Miyai K.
    J Clin Endocrinol Metab; 1987 Aug; 65(2):324-30. PubMed ID: 2885336
    [Abstract] [Full Text] [Related]

  • 3. Transient recurrence of hyperthyroidism after delivery in Graves' disease.
    Amino N, Miyai K, Yamamoto T, Kuro R, Tanaka F.
    J Clin Endocrinol Metab; 1977 Jan; 44(1):130-6. PubMed ID: 576228
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Differences between changes in serum thyrotropin-binding inhibitory antibodies and thyroid-stimulating antibodies in the course of antithyroid drug therapy for Graves' disease.
    Yamano Y, Takamatsu J, Sakane S, Hirai K, Kuma K, Ohsawa N.
    Thyroid; 1999 Aug; 9(8):769-73. PubMed ID: 10482368
    [Abstract] [Full Text] [Related]

  • 6. Role of thyrotropin receptor antibodies in the development of hyperthyroidism: follow-up studies on nine patients with Graves' disease.
    Kasagi K, Tamai H, Morita T, Hidaka A, Hatabu H, Misaki T, Iida Y, Ishihara T, Ikekubo K, Kuma K.
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1189-94. PubMed ID: 2566620
    [Abstract] [Full Text] [Related]

  • 7. Prediction of post-partum Graves' thyrotoxicosis by measurement of thyroid stimulating antibody in early pregnancy.
    Hidaka Y, Tamaki H, Iwatani Y, Tada H, Mitsuda N, Amino N.
    Clin Endocrinol (Oxf); 1994 Jul; 41(1):15-20. PubMed ID: 7914152
    [Abstract] [Full Text] [Related]

  • 8. The mechanism of spontaneous hypothyroidism in patients with Graves' disease after antithyroid drug treatment.
    Tamai H, Hirota Y, Kasagi K, Matsubayashi S, Kuma K, Iida Y, Konishi J, Okimura MC, Walter RM, Kumagai LF.
    J Clin Endocrinol Metab; 1987 Apr; 64(4):718-22. PubMed ID: 2434520
    [Abstract] [Full Text] [Related]

  • 9. The role of thyroid stimulating antibody (TSAb) in the thyroid function of patients with post-partum hypothyroidism.
    Hara T, Tamai H, Mukuta T, Fukata S, Kuma K.
    Clin Endocrinol (Oxf); 1992 Jan; 36(1):69-74. PubMed ID: 1348451
    [Abstract] [Full Text] [Related]

  • 10. [A study using FRTL-5 cell for detecting thyroid stimulating antibody activity in serum in patients with Graves disease].
    Li J, Gao H, Jin SX.
    Zhonghua Nei Ke Za Zhi; 1991 Jul; 30(7):392-4, 454. PubMed ID: 1684315
    [Abstract] [Full Text] [Related]

  • 11. Relationship between silent thyroiditis and recurrent Graves' disease in the postpartum period.
    Momotani N, Noh J, Ishikawa N, Ito K.
    J Clin Endocrinol Metab; 1994 Jul; 79(1):285-9. PubMed ID: 7913091
    [Abstract] [Full Text] [Related]

  • 12. Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Graves' hyperthyroidism.
    Romaldini JH, Bromberg N, Werner RS, Tanaka LM, Rodrigues HF, Werner MC, Farah CS, Reis LC.
    J Clin Endocrinol Metab; 1983 Sep; 57(3):563-70. PubMed ID: 6192139
    [Abstract] [Full Text] [Related]

  • 13. Low response of the thyroid gland to endogenous thyrotropin increased by thyrotropin-releasing hormone in patients with euthyroid Graves' disease.
    Kashiwai T, Tada H, Watanabe Y, Shimaoka Y, Yagoro A, Hidaka Y, Fujikado T, Amino N.
    Thyroid; 1998 Oct; 8(10):881-5. PubMed ID: 9827654
    [Abstract] [Full Text] [Related]

  • 14. A TSHR-LH/CGR chimera that measures functional thyroid-stimulating autoantibodies (TSAb) can predict remission or recurrence in Graves' patients undergoing antithyroid drug (ATD) treatment.
    Giuliani C, Cerrone D, Harii N, Thornton M, Kohn LD, Dagia NM, Bucci I, Carpentieri M, Di Nenno B, Di Blasio A, Vitti P, Monaco F, Napolitano G.
    J Clin Endocrinol Metab; 2012 Jul; 97(7):E1080-7. PubMed ID: 22492869
    [Abstract] [Full Text] [Related]

  • 15. Pregnancy-associated changes in the thyroid-stimulating antibody of Graves' disease and the relationship to neonatal hyperthyroidism.
    Zakarija M, McKenzie JM.
    J Clin Endocrinol Metab; 1983 Nov; 57(5):1036-40. PubMed ID: 6137493
    [Abstract] [Full Text] [Related]

  • 16. A change from stimulatory to blocking antibody activity in Graves' disease during pregnancy.
    Kung AW, Jones BM.
    J Clin Endocrinol Metab; 1998 Feb; 83(2):514-8. PubMed ID: 9467567
    [Abstract] [Full Text] [Related]

  • 17. Aggravation of thyrotoxicosis in early pregnancy and after delivery in Graves' disease.
    Amino N, Tanizawa O, Mori H, Iwatani Y, Yamada T, Kurachi K, Kumahara Y, Miyai K.
    J Clin Endocrinol Metab; 1982 Jul; 55(1):108-12. PubMed ID: 6896207
    [Abstract] [Full Text] [Related]

  • 18. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.
    Murakami M, Koizumi Y, Aizawa T, Yamada T, Takahashi Y, Watanabe T, Kamoi K.
    J Clin Endocrinol Metab; 1988 Jan; 66(1):103-8. PubMed ID: 3121661
    [Abstract] [Full Text] [Related]

  • 19. Epitope mapping of tsh receptor-blocking antibodies in Graves' disease that appear during pregnancy.
    Kung AW, Lau KS, Kohn LD.
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3647-53. PubMed ID: 11502791
    [Abstract] [Full Text] [Related]

  • 20. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies.
    Eckstein AK, Plicht M, Lax H, Hirche H, Quadbeck B, Mann K, Steuhl KP, Esser J, Morgenthaler NG.
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):612-8. PubMed ID: 15521965
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.